The HSP90 Inhibitor Onalespib Exerts Synergistic Anti-Cancer Effects When Combined With Radiotherapy: An in Vitro and in Vivo Approach
Scientific Reports - United Kingdom
doi 10.1038/s41598-020-62293-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 3, 2020
Authors
Publisher
Springer Science and Business Media LLC